DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.04+0.43 (+0.53%)
Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –
DexCom total assets
Total assets on the balance sheet at the end of each period.
DexCom's total assets was $6.24B at Sep 30, 2026. For fiscal 2025 it was $6.34B, down 2.2% from the year before. Over ten years it grew 36.0% a year on average. The highest annual figure on record is $6.48B in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.34B | -2.2% |
| FY2024 | Dec 31, 2024 | $6.48B | +3.5% |
| FY2023 | Dec 31, 2023 | $6.26B | +16.2% |
| FY2022 | Dec 31, 2022 | $5.39B | +9.3% |
| FY2021 | Dec 31, 2021 | $4.93B | +15.0% |
| FY2020 | Dec 31, 2020 | $4.29B | +79.1% |
| FY2019 | Dec 31, 2019 | $2.40B | +25.0% |
| FY2018 | Dec 31, 2018 | $1.92B | +111.9% |
| FY2017 | Dec 31, 2017 | $904.10M | +124.5% |
| FY2016 | Dec 31, 2016 | $402.80M | +37.9% |
| FY2015 | Dec 31, 2015 | $292.00M | +58.2% |
| FY2014 | Dec 31, 2014 | $184.60M | +50.7% |
| FY2013 | Dec 31, 2013 | $122.50M | +15.6% |
| FY2012 | Dec 31, 2012 | $106.00M | -12.0% |
| FY2011 | Dec 31, 2011 | $120.50M | +56.2% |
| FY2010 | Dec 31, 2010 | $77.16M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.24B | -16.8% |
| Q2 FY2026 | Jun 30, 2026 | $6.46B | -11.9% |
| Q1 FY2026 | Mar 31, 2026 | $6.63B | -1.8% |
| Q4 FY2025 | Dec 31, 2025 | $6.34B | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $7.50B | +18.0% |
| Q2 FY2025 | Jun 30, 2025 | $7.33B | +7.8% |
| Q1 FY2025 | Mar 31, 2025 | $6.75B | +4.2% |
| Q4 FY2024 | Dec 31, 2024 | $6.48B | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | $6.35B | -3.7% |
| Q2 FY2024 | Jun 30, 2024 | $6.80B | -0.3% |
| Q1 FY2024 | Mar 31, 2024 | $6.48B | +17.5% |
| Q4 FY2023 | Dec 31, 2023 | $6.26B | +16.2% |
| Q3 FY2023 | Sep 30, 2023 | $6.60B | +34.6% |
| Q2 FY2023 | Jun 30, 2023 | $6.82B | +30.7% |
| Q1 FY2023 | Mar 31, 2023 | $5.52B | +9.1% |
| Q4 FY2022 | Dec 31, 2022 | $5.39B | +9.3% |
| Q3 FY2022 | Sep 30, 2022 | $4.90B | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | $5.22B | +15.8% |
| Q1 FY2022 | Mar 31, 2022 | $5.06B | +15.2% |
| Q4 FY2021 | Dec 31, 2021 | $4.93B | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | $4.78B | +24.6% |
| Q2 FY2021 | Jun 30, 2021 | $4.50B | +27.9% |
| Q1 FY2021 | Mar 31, 2021 | $4.39B | +79.3% |
| Q4 FY2020 | Dec 31, 2020 | $4.29B | +79.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.83B | +75.4% |
| Q2 FY2020 | Jun 30, 2020 | $3.52B | +70.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.45B | +24.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.40B | +25.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.19B | +96.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.07B | +105.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.97B | +120.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.92B | +111.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.11B | +32.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.01B | +26.6% |
| Q1 FY2018 | Mar 31, 2018 | $896.80M | +92.0% |
| Q4 FY2017 | Dec 31, 2017 | $904.10M | +124.5% |
| Q3 FY2017 | Sep 30, 2017 | $842.90M | – |
| Q2 FY2017 | Jun 30, 2017 | $795.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $467.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $402.80M | – |
See a number that looks wrong?